News

A researcher developing 3D bioprinted mesh for use in treating pelvic organ prolapse (POP) has received a Victoria Fellowship, allowing him to travel overseas to further his research into bioinks.…  Read more

A colon cancer research breakthrough at Hudson Institute has shown that combining two types of drugs targeting gene expression stops cancer proliferation.…  Read more

An international team developing new technologies for vaginal reconstruction has been awarded a prestigious million-dollar prize.…  Read more

A new understanding of the causes of small cell lung cancer (SCLC) could lead to more personalised treatments and lower mortality from this deadly disease.…  Read more

An ambitious project to identify and characterise the rarest and deadliest forms of brain cancer in children has received a welcome funding boost.…  Read more

Neural Stem Cells have strong potential to be effective in reducing brain injury in newborn babies, in the most extensive review of research on the topic.…  Read more

A promising early intervention treatment for cerebral palsy in newborn babies has proven effective in both boys and girls – even though it works differently depending on the sex of the offspring.…  Read more

A bacterium present in half the world’s population, Helicobacter pylori  is the target of new research aiming to develop a vaccine against stomach cancer.  …  Read more

RNA technology developed by Hudson Institute of Medical Research with the potential to limit inflammatory side-effects of RNA therapeutics such as mRNA vaccines, is the subject of a new licensing deal.…  Read more

Newborn babies who suffer asphyxia at birth could face significantly less risk of disability, thanks to a new treatment developed by Hudson Institute and Monash University scientists.…  Read more